These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15789470)

  • 1. High antiretroviral drug adherence key in effort to avoid drug resistance. New study highlights its importance.
    AIDS Alert; 2005 Mar; 20(3):25, 27-8. PubMed ID: 15789470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
    AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why do patients fail HIV therapy?
    Waters L; Nelson M
    Int J Clin Pract; 2007 Jun; 61(6):983-90. PubMed ID: 17504360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiretroviral therapy. Simpler and more tolerable with equally high effectiveness].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():78-9. PubMed ID: 16385885
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.
    Masquelier B; Pereira E; Peytavin G; Descamps D; Reynes J; Verdon R; Fleury H; Garraffo R; Chêne G; Raffi F; Brun-Vézinet F;
    J Clin Virol; 2005 May; 33(1):75-8. PubMed ID: 15797369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving adherence to antiretroviral therapies: challenges and strategies.
    HIV Inside; 2002; 4(2):1, 3-12. PubMed ID: 12400482
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug Guide 2000: the antiretroviral agents.
    Gallant JE
    Posit Aware; 2000; 11(1):30-1. PubMed ID: 11366347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence strategies. Monitoring of treatment can help ART resistance. Sustained treatment interruption is worst.
    AIDS Alert; 2008 Oct; 23(10):113-4. PubMed ID: 18935683
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal drug treatment regimens for HIV depend on adherence.
    Krakovska O; Wahl LM
    J Theor Biol; 2007 Jun; 246(3):499-509. PubMed ID: 17320115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV adherence survey findings at a glance.
    AIDS Alert; 2001 Jun; 16(6):77, 70. PubMed ID: 11569968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring HIV treatment adherence in clinical practice.
    Hecht FM
    AIDS Clin Care; 1998 Aug; 10(8):57-9. PubMed ID: 11365682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence: a necessity for successful HIV combination therapy.
    Chesney MA; Ickovics J; Hecht FM; Sikipa G; Rabkin J
    AIDS; 1999; 13 Suppl A():S271-8. PubMed ID: 10885784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study.
    Torti C; Quiros-Roldan E; Regazzi M; De Luca A; Mazzotta F; Antinori A; Ladisa N; Micheli V; Orani A; Patroni A; Villani P; Lo Caputo S; Moretti F; Di Giambenedetto S; Castelnuovo F; Maggi P; Tinelli C; Carosi G;
    Clin Infect Dis; 2005 Jun; 40(12):1828-36. PubMed ID: 15909273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accrued HIV evidence turns treatment dogma on its head.
    Check E
    Nature; 2003 Aug; 424(6951):866. PubMed ID: 12931150
    [No Abstract]   [Full Text] [Related]  

  • 17. Adherence matters. Hospitalization may interrupt meds.
    Wongvipat N
    Posit Living; 1999 Jul; 8(6):20. PubMed ID: 12492053
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
    Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD;
    AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.
    Lagnese M; Daar ES
    Expert Opin Pharmacother; 2008 Apr; 9(5):687-700. PubMed ID: 18345948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.
    Ribera E; Rodríguez-Pardo D; Rubio M; Soler A; Pedrol E; Blanco JL; González A; Crespo M; Falcó V; Ocaña I; Deig E; Miró JM; Pahissa A
    Antivir Ther; 2005; 10(5):605-14. PubMed ID: 16152754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.